No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Yunnan Jianzhijia Health-Chain Co., Ltd. operates a significant pharmaceutical retail enterprise throughout China. This company oversees an extensive chain of roughly 1,200 proprietary stores, complemented by its digital pharmacy platform. Shoppers can find a broad spectrum of items, encompassing household medications, vision care products like contact lenses and their solutions, various medical devices, sexual wellness goods, nutritional supplements, traditional Chinese herbal medicines, personal hygiene articles, infant products, and even ready-to-eat convenience foods. Established in Kunming, China, in 2004, the company maintains its headquarters there.
www.jzj.cnNo one on the platform currently holds 605266.SS.
No tracked institution reports a position in 605266.SS as of their last filing.
No one on the platform has traded 605266.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.1% | 7.0% | 42.3% | — | — | — |
| Rev. Growth % | -3.9% | 14.8% | ||||
| Profit Margin % | 1.7% | 3.7% | 4.1% | |||
| Free Cash Flow Margin % | 11.5% | 6.9% | 5.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $11.8B | +12.8% | $2.04 | $2.04–$2.04 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-04-28 | $1.13 | $0.22 | -80.5% |
| 2024-10-29 | $0.92 | $0.24 | -73.8% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 605266.SSJianzhijia Pharmaceutical Chain Group Co., Ltd. | $15.16 | -0.39% | $2.3B | — |
| 000153.SZAnhui Fengyuan Pharmaceutical Co., Ltd. | $5.99 | -0.17% | $2.8B | — |
| 002412.SZHunan Hansen Pharmaceutical Co., Ltd. | $8.66 | -0.35% | $4.4B | — |
| 002788.SZLuyan Pharma Co.,Ltd. | $10.77 | +3.16% | $4.2B | — |
| 002864.SZShaanxi Panlong Pharmaceutical Group Limited By Share Ltd |
| $20.18 |
| -0.88% |
| $2.8B |
| — |
| 300452.SZAnhui Sunhere Pharmaceutical Excipients Co.,Ltd. | $12.55 | -0.40% | $2.9B | — |
| 300562.SZGuangdong Transtek Medical Electronics Co., Ltd | $16.70 | -0.24% | $3.7B | — |
Source: Financial Modeling Prep · peers by sector/industry